Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

Benzinga · 08/15 12:46
Shares of KULR Technology Group, Inc. (NYSE:KULR) rose sharply in pre-market trading after the company reported better-than-expected quarterly financial results.
KULR Technology reported second-quarter revenue of $3.97 million, beating estimates of $3.5 million, according to Benzinga Pro. KULR Technology reported second-quarter earnings of 22 cents per share, beating estimates for a loss of 16 cents per share.
KULR Technology shares jumped 19.3% to $6.29 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Perfect Moment Ltd. (NYSE:PMNT) climbed 151% to $0.7344 in pre-market trading after the company quarterly financial results.
- Precigen, Inc. (NASDAQ:PGEN) shares gained 56.3% to $2.8899 in pre-market trading after the company announced the FDA has approved PAPZIMEOS. HC Wainwright & Co. raised its price target on the stock from 6 to $8.5.
- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) gained 47.4% to $0.3915 in pre-market trading after the company reported better-than-expected quarterly financial results.
- Pioneer Power Solutions, Inc. (NASDAQ:PPSI) gained 45.3% to $4.52 in pre-market trading after the company reported a second-quarter EPS beat and issued FY25 sales guidance with its midpoint above estimates.
- Co-Diagnostics, Inc (NASDAQ:CODX) jumped 41.4% to $0.3754 in pre-market trading after the company reported better-than-expected quarterly financial results.
- Vision Marine Technologies Inc. (NASDAQ:VMAR) rose 29.2% to $3.67 in pre-market trading after the company announced the New York State County Supreme Court has formally approved its settlement regarding a legal claim related to certain shareholders.
- Replimune Group, Inc. (NASDAQ:REPL) gained 13.3% to $6.06 in pre-market trading after gaining 5% on Thursday.
- UnitedHealth Group Incorporated (NYSE:UNH) jumped 10% to $298.75 in pre-market trading following disclosure that legendary investors Michael Burry and Warren Buffett have taken significant positions in the healthcare giant.
- Hesai Group (NASDAQ:HSAI) surged 8.4% to $25.28 in pre-market trading after the company reported a year-over-year increase in quarterly financial results. Additionally, the company announced a new lidar design win from Toyota.
Losers
- Origin Materials, Inc. (NASDAQ:ORGN) dipped 36.8% to $0.53 in pre-market trading after the company reported a year-over-year decrease in quarterly sales results.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) tumbled 16.2% to $49.96 in pre-market trading.
- Applied Materials, Inc. (NASDAQ:AMAT) dipped 14.7% to $160.51 in pre-market trading after the company issued weak fourth-quarter guidance.
- Gambling.com Group Limited (NASDAQ:GAMB) shares tumbled 13.4% to $8.98 in pre-market trading after the company reported second-quarter results.
- Globant S.A. (NYSE:GLOB) dipped 11.8% to $68.75 in pre-market trading after the company issued FY25 sales guidance below estimates.
- Sandisk Corporation (NASDAQ:SNDK) declined 11.1% to $41.50 in pre-market trading. Sandisk reported upbeat earnings for its fourth quarter. Sandisk expects fiscal first-quarter revenue to be between $2.1 billion and $2.2 billion, versus estimates of $1.99 billion. The company also guided for first-quarter adjusted earnings of 70 cents to 90 cents per share, versus estimates of 84 cents per share, per Benzinga Pro
- 180 Life Sciences Corp (NASDAQ:ATNF) fell 7.8% to $7.02 in pre-market trading after dipping 29% on Thursday.
- KLA Corporation (NASDAQ:KLAC) shares fell 6.1% to $897.00 in pre-market trading.
- Lam Research Corporation (NASDAQ:LRCX) declined 5.8% to $101.21 in pre-market trading.
- So-Young International Inc. (NASDAQ:SY) shares fell 4.9% to $4.61 in pre-market trading after posting a loss for the second quarter.
Now Read This:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.